Skip to content

MassBio

Massachusetts Biotechnology Council

Open search form
  • Sign In
  • Become a Member Org.
  • MB Vision
  • Members
    • Become a Member
    • Benefits
      • Savings and Rewards
    • Member News
    • Member Events
    • Directory
    • Career Center
    • FAQs
    • Pay Company Dues
  • Events
    • Upcoming
    • Types of Events
    • Sponsorship Opportunities
    • The State of Possible Conference
    • Align Summit
    • Member Events
  • Innovation
    • About
    • MassBioDrive
      • Application
      • Alumni
      • Partners
      • Get Involved
      • FAQs
    • CEO & Founder Link
    • Align Summit
    • Partnering
    • Sponsorship Opportunities
  • Savings
    • MassBioEdge
  • Conference Center
    • About MassBioHub
    • Packages & Special Offers
    • Venue Specifications
    • Reserve Today
  • Policy & Advocacy
    • Policy & Advocacy Efforts
    • Diversity, Equity, and Inclusion
      • DEI Report
      • Resource Center
      • Open Letter 2.0
      • Bioversity
    • Economic Development
      • BioReady® Communities
    • Workforce Development
      • Bioversity
    • Vision 2030
    • Industry Reports
      • Industry Snapshot
      • Biopharma Funding Report
      • DEI Report
      • MA Life Sciences Workforce
  • About
    • About MassBio
    • MB Vision
    • News & Thought Leadership
    • The Studio at Kendall Square
    • Sponsorship Opportunities
    • Staff
    • Board
    • Contact Us
  • Sign In
  • Become a Member Org.
  • MB Vision
Open search form

Member News

Click to Open Main Menu
News

Meet Algorics at Booth 6 in Belfast this November at the at PHUSE EU Connect 2022

Nov 08, 2022

News

Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition

Nov 03, 2022

Posted by Sumitomo Pharma Oncology, Inc.

News

Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia

Nov 03, 2022

Posted by Sumitomo Pharma Oncology, Inc.

News

EdiGene to Present Preliminary Safety and Efficacy Results of an Investigator Initiated Trial for ET-01, its Investigational Gene Editing Hematopoietic Stem Cell Therapy, at the 64th American Society

Nov 03, 2022

Case Studies

Using molecular dynamics to produce an ensemble of protein conformations for more biologically-relevant docking experiments

Nov 03, 2022

Posted by Cresset

Case Studies

Identifying novel inhibitors against tuberculosis

Nov 03, 2022

Posted by Cresset

News

Data-driven Generation of Perturbation Networks for Relative Binding Free Energy Calculations

Nov 02, 2022

Posted by Cresset

News

Flexible software and consulting solutions for academics

Nov 02, 2022

Posted by Cresset

News

Greenberg Traurig’s Jeffrey W. Greene Named a ‘Massachusetts Go To Lawyer: Cybersecurity and Data Privacy 2022’

Nov 02, 2022

Posted by Greenberg Traurig, LLP

News

Greenberg Traurig’s Mian R. Wang Elected to MCLE Board of Trustees

Nov 01, 2022

Posted by Greenberg Traurig, LLP

Page 62 of 203FIRSTPrev...102030...6061626364...708090...NextLAST

Massachusetts Biotechnology Council

700 Technology Square, 5th Floor
Cambridge, MA 02139
617.674.5100

  • News & Thought Leadership
  • Pay Company Dues
  • Join Today
  • Contact
  • Privacy Policy
  • Fulfillment Policy
  • © 2024 All Rights Reserved